Company Filing History:
2 out of 832,912 Years Active: 2003
Title: Werner Sieghart: Innovator in Nervous Disorder Treatments
Introduction
Werner Sieghart is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating nervous disorders. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry significantly.
Latest Patents
Sieghart's latest patents include innovative compounds such as N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones. These compounds are designed for use as promoters of γ-aminobutyric acid activity and for treating nervous disorders. The invention details compounds represented by a specific general formula, where various groups represent different chemical structures. Additionally, he has developed N-substituted 1-(lactone) isoquinolones, which also target nervous disorders by stimulating γ-aminobutyric acid activity.
Career Highlights
Throughout his career, Sieghart has worked with various organizations, including the UWM Research Foundation, Inc. His research has focused on creating pharmaceutical compositions that contain his innovative compounds, which are intended for medical use in treating nervous disorders.
Collaborations
Some of his notable collaborators include Robert H. Dodd and Frantisek Jursky. Their combined expertise has contributed to the advancement of research in the field of medicinal chemistry.
Conclusion
Werner Sieghart's contributions to the development of treatments for nervous disorders highlight his innovative spirit and dedication to improving healthcare. His patents represent a significant step forward in the search for effective medicinal solutions.